Kestra Medical Technologies, Ltd.
KMTS
$26.17
$1.265.06%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 53.40% | 51.55% | 71.40% | 82.31% | 210.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 53.40% | 51.55% | 71.40% | 82.31% | 210.24% |
| Cost of Revenue | 25.46% | 22.58% | 10.89% | 15.49% | 55.82% |
| Gross Profit | 95.95% | 110.74% | 446.39% | 643.98% | 708.88% |
| SG&A Expenses | 78.52% | 75.42% | 181.50% | 39.23% | 22.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.50% | 54.58% | 115.26% | 26.46% | 24.77% |
| Operating Income | -65.96% | -56.68% | -136.93% | -3.28% | 14.52% |
| Income Before Tax | -58.89% | -26.96% | -128.63% | -0.63% | 17.84% |
| Income Tax Expenses | 325.00% | 371.43% | 477.78% | 28.57% | -56.76% |
| Earnings from Continuing Operations | -58.99% | -27.08% | -129.36% | -0.65% | 17.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.96% | -29.88% | -133.59% | 0.51% | 18.88% |
| EBIT | -65.96% | -56.68% | -136.93% | -3.28% | 14.52% |
| EBITDA | -70.18% | -67.23% | -175.28% | -12.84% | 13.83% |
| EPS Basic | 46.44% | 55.05% | -84.39% | -5.98% | 99.53% |
| Normalized Basic EPS | 37.27% | 49.03% | -106.96% | 1.21% | 99.55% |
| EPS Diluted | 46.44% | 55.05% | -84.39% | -5.98% | 99.53% |
| Normalized Diluted EPS | 37.27% | 49.03% | -106.96% | 1.21% | 99.55% |
| Average Basic Shares Outstanding | 158.36% | 158.00% | 23.63% | 0.00% | 18,695.27% |
| Average Diluted Shares Outstanding | 158.36% | 158.00% | 23.63% | 0.00% | 18,695.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |